News
12-10-2009, 06:12 AM
Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, has completed a Phase 3 clinical trial of Lymphoseek® (NEO3-05) with positive results...
More... (http://www.medicalnewstoday.com/articles/173516.php)
More... (http://www.medicalnewstoday.com/articles/173516.php)